BMRN INVESTOR FRAUD: Hagens Berman, National Trial Attorneys, Encourages BioMarin Pharmaceutical (BMRN) Investors to Contact Its Attorneys, Securities Fraud Class Action Filed
September 29, 2020 16:40 ET
|
Hagens Berman Sobol Shapiro LLP
SAN FRANCISCO, Sept. 29, 2020 (GLOBE NEWSWIRE) -- Hagens Berman urges BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) investors to contact the firm now. A securities fraud class action has been filed...